tetano
Editor, Senior Moderator
QuantPlex RV-16 Assay will enable physicians to develop personalized medicine regimens for patients
Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, announced on Monday the development of a new molecular assay for the quantification of twenty-onerespiratory viral pathogens associated with respiratory disease. QuantPlex RV-16 Assay will give physicians the specific information needed to guide patient treatment decisions, and answer questions that previously have gone unasked and / or unanswered.
Acute respiratory disease is a serious source of infection around the world. The majority of respiratory infections (approximately 80%) are viral in nature. Within the pediatric population, respiratory viral infections account for a considerable proportion of emergency room visits. Accurate and reliable detection and differentiation of these respiratory viral pathogens is needed to assess and treat a patient's particular disease state.
...
http://www.medicalnewstoday.com/releases/246826.php
Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, announced on Monday the development of a new molecular assay for the quantification of twenty-onerespiratory viral pathogens associated with respiratory disease. QuantPlex RV-16 Assay will give physicians the specific information needed to guide patient treatment decisions, and answer questions that previously have gone unasked and / or unanswered.
Acute respiratory disease is a serious source of infection around the world. The majority of respiratory infections (approximately 80%) are viral in nature. Within the pediatric population, respiratory viral infections account for a considerable proportion of emergency room visits. Accurate and reliable detection and differentiation of these respiratory viral pathogens is needed to assess and treat a patient's particular disease state.
...
http://www.medicalnewstoday.com/releases/246826.php